New Oral Peptidomimetics Potently Stimulate Growth Hormone Release
Background
Growth Hormone (GH) plays a crucial role in growth, metabolism, and body composition, but its deficiency can lead to various health issues like growth retardation and muscle wasting. While peptide-based GH secretagogues exist, the development of orally active, non-peptidyl compounds remains a significant challenge due to issues with stability and bioavailability. This study aimed to discover a new class of potent, orally active GH secretagogues by mimicking the structural features of existing privileged structures.
Results
Among the synthesized compounds, compound 18 emerged as particularly potent, demonstrating an EC50 (half maximal effective concentration) of just 2.8 nM for stimulating GH release from rat pituitary cells. This indicates a very high affinity and efficacy at low concentrations. This potency makes compound 18 nearly as effective as MK-0677, a well-established and potent GH secretagogue, in promoting GH secretion. The study successfully identified a new class of compounds that are not only potent but also described as being orally active, a crucial characteristic for potential therapeutic agents. This suggests a significant advancement in the search for non-peptidyl GH secretagogues, offering a promising alternative to injectable therapies.
Why It Matters
The discovery of potent, orally active Growth Hormone (GH) secretagogues like compound 18 is highly significant because it offers a non-invasive alternative to injectable peptide-based therapies. Such compounds could potentially be used to treat conditions associated with GH deficiency, such as growth retardation in children or age-related muscle wasting (sarcopenia) in adults. This research lays foundational groundwork for the development of new oral medications that could improve quality of life for patients needing GH stimulation. Future steps would involve in vivo studies to confirm oral bioavailability and efficacy in animal models, followed by human clinical trials to assess safety and therapeutic potential.